Matthew Harrison
Stock Analyst at Morgan Stanley
(3.33)
# 978
Out of 4,876 analysts
703
Total ratings
47.64%
Success rate
2.18%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintains: Equal-Weight | $464 → $460 | $443.40 | +3.74% | 39 | Jun 20, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Equal-Weight | $113 → $40 | $17.23 | +132.15% | 37 | Jun 17, 2025 | |
| INSM Insmed | Maintains: Overweight | $90 → $102 | $101.74 | +0.26% | 17 | Jun 11, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Overweight | $958 → $755 | $521.00 | +44.91% | 52 | Jun 2, 2025 | |
| GILD Gilead Sciences | Maintains: Overweight | $130 → $135 | $107.62 | +25.44% | 42 | Apr 25, 2025 | |
| AVIR Atea Pharmaceuticals | Maintains: Equal-Weight | $6.2 → $6 | $3.53 | +69.97% | 10 | Apr 11, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $157 → $152 | $126.92 | +19.76% | 52 | Apr 9, 2025 | |
| MRNA Moderna | Maintains: Equal-Weight | $39 → $32 | $27.54 | +16.19% | 25 | Apr 9, 2025 | |
| LEGN Legend Biotech | Maintains: Overweight | $82 → $80 | $33.48 | +138.95% | 11 | Mar 17, 2025 | |
| TNYA Tenaya Therapeutics | Maintains: Overweight | $15 → $5 | $0.69 | +623.07% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $41 → $33 | $14.50 | +127.66% | 12 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $178 | $147.20 | +20.92% | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $33.05 | +69.44% | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $35.21 | +56.21% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $1.50 | +100.67% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $4 → $6 | $1.46 | +310.96% | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $13.04 | -15.64% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $38 → $8 | $1.26 | +534.92% | 4 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $510 | $560.04 | -8.94% | 24 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $2.12 | +230.19% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $112 | $54.10 | +107.02% | 21 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 | $17.44 | +94.95% | 14 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $20.73 | +54.37% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $2.65 | +616.98% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $13 | $7.95 | +63.52% | 4 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $0.80 | +25.17% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $20.36 | -50.88% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $7.38 | +8.40% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $28.07 | +56.75% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $2.87 | +352.96% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $80 | $9.12 | +777.19% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $60 | $5.76 | +941.67% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $106.14 | +103.50% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $2.70 | +85.19% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $1.91 | +161.78% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $186.79 | -2.56% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $3.78 | +138.10% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $30 → $40 | $56.28 | -28.93% | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $279.11 | +1.04% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $318.25 | -34.01% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $24.24 | +114.52% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $152.01 | +13.81% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $61 → $57 | $9.28 | +514.22% | 9 | Mar 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $37.13 | +223.19% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $14.74 | +904.07% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $78.83 | +4.02% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $46.65 | +41.48% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $2.41 | +1,518.26% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $35.27 | +30.42% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $9.98 | +250.70% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $795.12 | -65.41% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $2.39 | +694.98% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $8.75 | +608.57% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $16.64 | +3.67% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $50 | $0.79 | +6,269.43% | 4 | Aug 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $70.81 | +17.22% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $59 → $57 | $29.64 | +92.31% | 4 | Oct 11, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $33.91 | -70.51% | 4 | Sep 10, 2018 |
Vertex Pharmaceuticals
Jun 20, 2025
Maintains: Equal-Weight
Price Target: $464 → $460
Current: $443.40
Upside: +3.74%
Sarepta Therapeutics
Jun 17, 2025
Downgrades: Equal-Weight
Price Target: $113 → $40
Current: $17.23
Upside: +132.15%
Insmed
Jun 11, 2025
Maintains: Overweight
Price Target: $90 → $102
Current: $101.74
Upside: +0.26%
Regeneron Pharmaceuticals
Jun 2, 2025
Maintains: Overweight
Price Target: $958 → $755
Current: $521.00
Upside: +44.91%
Gilead Sciences
Apr 25, 2025
Maintains: Overweight
Price Target: $130 → $135
Current: $107.62
Upside: +25.44%
Atea Pharmaceuticals
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $6.2 → $6
Current: $3.53
Upside: +69.97%
Biogen
Apr 9, 2025
Maintains: Equal-Weight
Price Target: $157 → $152
Current: $126.92
Upside: +19.76%
Moderna
Apr 9, 2025
Maintains: Equal-Weight
Price Target: $39 → $32
Current: $27.54
Upside: +16.19%
Legend Biotech
Mar 17, 2025
Maintains: Overweight
Price Target: $82 → $80
Current: $33.48
Upside: +138.95%
Tenaya Therapeutics
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $0.69
Upside: +623.07%
Mar 7, 2025
Assumes: Overweight
Price Target: $41 → $33
Current: $14.50
Upside: +127.66%
Feb 21, 2025
Maintains: Buy
Price Target: $160 → $178
Current: $147.20
Upside: +20.92%
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $33.05
Upside: +69.44%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $35.21
Upside: +56.21%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $1.50
Upside: +100.67%
Sep 16, 2024
Maintains: Overweight
Price Target: $4 → $6
Current: $1.46
Upside: +310.96%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $13.04
Upside: -15.64%
Jun 18, 2024
Downgrades: Equal-Weight
Price Target: $38 → $8
Current: $1.26
Upside: +534.92%
May 28, 2024
Maintains: Overweight
Price Target: $515 → $510
Current: $560.04
Upside: -8.94%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $2.12
Upside: +230.19%
Apr 26, 2024
Maintains: Overweight
Price Target: $115 → $112
Current: $54.10
Upside: +107.02%
Apr 22, 2024
Maintains: Overweight
Price Target: $34
Current: $17.44
Upside: +94.95%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $20.73
Upside: +54.37%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $2.65
Upside: +616.98%
Mar 27, 2023
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $7.95
Upside: +63.52%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $0.80
Upside: +25.17%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $20.36
Upside: -50.88%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $7.38
Upside: +8.40%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $28.07
Upside: +56.75%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $2.87
Upside: +352.96%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $140 → $80
Current: $9.12
Upside: +777.19%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $100 → $60
Current: $5.76
Upside: +941.67%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $106.14
Upside: +103.50%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $2.70
Upside: +85.19%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $1.91
Upside: +161.78%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $186.79
Upside: -2.56%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $3.78
Upside: +138.10%
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $30 → $40
Current: $56.28
Upside: -28.93%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $279.11
Upside: +1.04%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $318.25
Upside: -34.01%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $24.24
Upside: +114.52%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $152.01
Upside: +13.81%
Mar 10, 2022
Maintains: Equal-Weight
Price Target: $61 → $57
Current: $9.28
Upside: +514.22%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $37.13
Upside: +223.19%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $14.74
Upside: +904.07%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $78.83
Upside: +4.02%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $46.65
Upside: +41.48%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $2.41
Upside: +1,518.26%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $35.27
Upside: +30.42%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $9.98
Upside: +250.70%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $795.12
Upside: -65.41%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $2.39
Upside: +694.98%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $8.75
Upside: +608.57%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $16.64
Upside: +3.67%
Aug 18, 2020
Downgrades: Equal-Weight
Price Target: $50
Current: $0.79
Upside: +6,269.43%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $70.81
Upside: +17.22%
Oct 11, 2018
Maintains: Overweight
Price Target: $59 → $57
Current: $29.64
Upside: +92.31%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $33.91
Upside: -70.51%